Figure 4.
Kaplan–Meier analysis for: (A) serum KL-6 at cut-off >1300 U/mL and (B) GK score at cut-off >2 points to separate patients at high risk (HR) and at low risk (LR) of disease progression. Higher score values indicate a higher risk for disease progression. Significance (Log rank p) is shown in the graphic.